| Sean P Ryan, MD | |
|
4104 State Highway 30, Amsterdam, NY 12010-6202 | |
| (518) 883-8634 | |
| (518) 843-8286 |
| Full Name | Sean P Ryan |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 27 Years |
| Location | 4104 State Highway 30, Amsterdam, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467430108 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 216322 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Nathan Littauer Hospital | Gloversville, NY | Hospital |
| St Mary's Healthcare | Amsterdam, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nathan Littauer Hospital Association | 4183618101 | 89 |
| New Dimensions In Living Inc | 8921089905 | 5 |
News Archive
Antigenics Inc. today announced that it has been awarded $424,720 in grants under the IRS' Qualifying Therapeutic Discovery Project (QTDP) program. The grants were awarded in recognition of our two qualifying programs: AG-707, a phase 1 therapeutic vaccine for the treatment of genital herpes and QS-21 Stimulon® adjuvant.
Scientists at the European Molecular Biology Laboratory (EMBL) and the University of Heidelberg, Germany, have come a step closer to understanding how cholesterol levels are regulated. In a study published today in the journal Cell Metabolism, the researchers identified 20 genes that are involved in this process. Besides giving scientists a better idea of where to look to uncover the mechanisms that ensure cholesterol balance is maintained, the discovery could lead to new treatments for cholesterol-related diseases.
As adults age, they accumulate a number of medications for chronic conditions. Older patients take anywhere between 5-15 medications per year, which increases the risk that some of the drugs will counteract each other.
XDx, Inc., a molecular diagnostics company focused on noninvasive gene expression tests to monitor immune-mediated conditions, today announced that it has entered into a multi-year agreement with Laboratory Corporation of America Holdings to provide heart transplant patients eligible for XDx's AlloMap® test with the convenience of having their blood drawn at participating LabCorp sites across the United States.
Even though Dr. David Nabarro, chief pandemic flu coordinator for the United Nations says he is encouraged by how both Thailand and Vietnam had responded to the health crisis facing their domestic poultry, and their successful efforts to reduce the threat of the disease, the deadly H5N1 strain still remains a significant threat, especially to Indonesia and Africa.
› Verified 3 days ago
| Entity Name | Nathan Littauer Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073541850 PECOS PAC ID: 4183618101 Enrollment ID: O20040413000599 |
News Archive
Antigenics Inc. today announced that it has been awarded $424,720 in grants under the IRS' Qualifying Therapeutic Discovery Project (QTDP) program. The grants were awarded in recognition of our two qualifying programs: AG-707, a phase 1 therapeutic vaccine for the treatment of genital herpes and QS-21 Stimulon® adjuvant.
Scientists at the European Molecular Biology Laboratory (EMBL) and the University of Heidelberg, Germany, have come a step closer to understanding how cholesterol levels are regulated. In a study published today in the journal Cell Metabolism, the researchers identified 20 genes that are involved in this process. Besides giving scientists a better idea of where to look to uncover the mechanisms that ensure cholesterol balance is maintained, the discovery could lead to new treatments for cholesterol-related diseases.
As adults age, they accumulate a number of medications for chronic conditions. Older patients take anywhere between 5-15 medications per year, which increases the risk that some of the drugs will counteract each other.
XDx, Inc., a molecular diagnostics company focused on noninvasive gene expression tests to monitor immune-mediated conditions, today announced that it has entered into a multi-year agreement with Laboratory Corporation of America Holdings to provide heart transplant patients eligible for XDx's AlloMap® test with the convenience of having their blood drawn at participating LabCorp sites across the United States.
Even though Dr. David Nabarro, chief pandemic flu coordinator for the United Nations says he is encouraged by how both Thailand and Vietnam had responded to the health crisis facing their domestic poultry, and their successful efforts to reduce the threat of the disease, the deadly H5N1 strain still remains a significant threat, especially to Indonesia and Africa.
› Verified 3 days ago
| Entity Name | New Dimensions In Living Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982674917 PECOS PAC ID: 8921089905 Enrollment ID: O20040526000480 |
News Archive
Antigenics Inc. today announced that it has been awarded $424,720 in grants under the IRS' Qualifying Therapeutic Discovery Project (QTDP) program. The grants were awarded in recognition of our two qualifying programs: AG-707, a phase 1 therapeutic vaccine for the treatment of genital herpes and QS-21 Stimulon® adjuvant.
Scientists at the European Molecular Biology Laboratory (EMBL) and the University of Heidelberg, Germany, have come a step closer to understanding how cholesterol levels are regulated. In a study published today in the journal Cell Metabolism, the researchers identified 20 genes that are involved in this process. Besides giving scientists a better idea of where to look to uncover the mechanisms that ensure cholesterol balance is maintained, the discovery could lead to new treatments for cholesterol-related diseases.
As adults age, they accumulate a number of medications for chronic conditions. Older patients take anywhere between 5-15 medications per year, which increases the risk that some of the drugs will counteract each other.
XDx, Inc., a molecular diagnostics company focused on noninvasive gene expression tests to monitor immune-mediated conditions, today announced that it has entered into a multi-year agreement with Laboratory Corporation of America Holdings to provide heart transplant patients eligible for XDx's AlloMap® test with the convenience of having their blood drawn at participating LabCorp sites across the United States.
Even though Dr. David Nabarro, chief pandemic flu coordinator for the United Nations says he is encouraged by how both Thailand and Vietnam had responded to the health crisis facing their domestic poultry, and their successful efforts to reduce the threat of the disease, the deadly H5N1 strain still remains a significant threat, especially to Indonesia and Africa.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sean P Ryan, MD 99 E State St, Gloversville, NY 12078-1203 Ph: (518) 773-5758 | Sean P Ryan, MD 4104 State Highway 30, Amsterdam, NY 12010-6202 Ph: (518) 883-8634 |
News Archive
Antigenics Inc. today announced that it has been awarded $424,720 in grants under the IRS' Qualifying Therapeutic Discovery Project (QTDP) program. The grants were awarded in recognition of our two qualifying programs: AG-707, a phase 1 therapeutic vaccine for the treatment of genital herpes and QS-21 Stimulon® adjuvant.
Scientists at the European Molecular Biology Laboratory (EMBL) and the University of Heidelberg, Germany, have come a step closer to understanding how cholesterol levels are regulated. In a study published today in the journal Cell Metabolism, the researchers identified 20 genes that are involved in this process. Besides giving scientists a better idea of where to look to uncover the mechanisms that ensure cholesterol balance is maintained, the discovery could lead to new treatments for cholesterol-related diseases.
As adults age, they accumulate a number of medications for chronic conditions. Older patients take anywhere between 5-15 medications per year, which increases the risk that some of the drugs will counteract each other.
XDx, Inc., a molecular diagnostics company focused on noninvasive gene expression tests to monitor immune-mediated conditions, today announced that it has entered into a multi-year agreement with Laboratory Corporation of America Holdings to provide heart transplant patients eligible for XDx's AlloMap® test with the convenience of having their blood drawn at participating LabCorp sites across the United States.
Even though Dr. David Nabarro, chief pandemic flu coordinator for the United Nations says he is encouraged by how both Thailand and Vietnam had responded to the health crisis facing their domestic poultry, and their successful efforts to reduce the threat of the disease, the deadly H5N1 strain still remains a significant threat, especially to Indonesia and Africa.
› Verified 3 days ago
Mr. James M. Charland, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 442a Guy Park Ave, Amsterdam, NY 12010 Phone: 518-842-0373 Fax: 518-842-0135 |